Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oncomedics

Oncomedics?uq=UG6efJS6
2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Crowdfunding LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of biotechnology research services intended to extract maximum information in order to derive the best possible treatment. The company's OncoTRIP platform allows for the determination of efficiency of human cells and different drugs, the response of population to several drugs and identification of population responsive and resistant to particular drugs, enabling clinicians and doctors to receive tested drugs and therapies for the immediate treatment of patients suffering from cancer.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1 avenue d'Ester
  • 87069 Limoges
  • France

+33 05 00 00 00 00

Oncomedics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Oncomedics‘s full profile, request access.

Request full access to PitchBook

Oncomedics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Oncomedics‘s full profile, request access.

Request full access to PitchBook

Oncomedics Executive Team (3)

Name Title Board
Seat
Contact
Info
Christophe Lautrette Ph.D Chief Executive Officer, Co-Founder & President
Stéphanie Giraud Ph.D Chief Scientific Officer & Co-Founder
Grégoire Prévost Ph.D Advisor